Model
Edge
PhaseBio Pharmaceuticals Inc
0001460751
Filing Type
4
Filing Date
10/25/2022
Updated
10/26/22, 10:41 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership